LIGAND PHARMACEUTICALS INC — Investor Relations & Filings
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that functions as a capital and technology partner to the life sciences industry. The company's business model focuses on acquiring and developing royalty-generating assets by investing in the clinical development and commercialization of medicines. It manages a large, diverse portfolio of economic rights to partnered programs across therapeutic areas such as oncology, kidney disease, diabetes, and rare conditions. In addition to its royalty business, Ligand develops and licenses its proprietary technology platforms to a global network of biopharmaceutical partners. Its key technologies include Captisol®, a chemically modified cyclodextrin used to improve the solubility and stability of active pharmaceutical ingredients, and the NITRICIL™ platform.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEFA14A | 2026-05-18 | English | |
| 8-K | 2026-05-18 | English | |
| 10-Q | 2026-05-08 | English | |
| 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-05-07 | English | |
| Major Shareholding Notification 2026 | 2026-05-01 | English | |
| Major Shareholding Notification 2026 | 2026-05-01 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46385520 | DEFA14A | 2026-05-18 | English | ||
| 46385526 | 8-K | 2026-05-18 | English | ||
| 46155763 | 10-Q | 2026-05-08 | English | ||
| 42834703 | 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-05-07 | English | ||
| 46155787 | Major Shareholding Notification 2026 | 2026-05-01 | English | ||
| 46155789 | Major Shareholding Notification 2026 | 2026-05-01 | English | ||
| 46155782 | 8-K | 2026-04-30 | English | ||
| 46155792 | DEFA14A | 2026-04-27 | English | ||
| 37461463 | 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-04-27 | English | ||
| 46155795 | ARS | 2026-04-21 | English | ||
| 46155796 | DEFA14A | 2026-04-21 | English | ||
| 34907767 | DEF 14A - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-04-21 | English | ||
| 33067636 | 4 - LIGAND PHARMACEUTICALS INC (0000886163) (Issuer) | 2026-03-28 | English | ||
| 33067397 | 4 - LIGAND PHARMACEUTICALS INC (0000886163) (Issuer) | 2026-03-28 | English | ||
| 33067331 | 4 - LIGAND PHARMACEUTICALS INC (0000886163) (Issuer) | 2026-03-28 | English | ||
Market data
Market data not available
Price history
Peer group · Other financial service activities n.e.c., except insurance and pension funding activities
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Crown Energy AB
An investment company transitioning from energy to focus on…
|
CRWEN | SE | Financial and insurance activit… |
|
CSC Financial Co., Ltd.
A leading full-service investment bank and brokerage firm o…
|
6066 | CN | Financial and insurance activit… |
|
Cubical Financial Services Ltd.
Provides credit facilities, investment management, and fina…
|
511710 | IN | Financial and insurance activit… |
|
Currency Exchange International, Corp.
Provider of foreign exchange, risk management, and integrat…
|
CXI | US | Financial and insurance activit… |
|
CVC LIMITED
Specializes in private equity, property finance, and strate…
|
CVC | AU | Financial and insurance activit… |
|
CVW Sustainable Royalties Inc.
A clean technology royalty platform recovering valuable res…
|
CVW | CA | Financial and insurance activit… |
|
DAISHIN SECURITIES CO.,LTD
Financial investment firm offering securities brokerage, un…
|
003540 | KR | Financial and insurance activit… |
|
Daiwa Securities Group Inc.
A financial services holding company with retail, wholesale…
|
8601 | JP | Financial and insurance activit… |
|
Dalal Street Investments Ltd.
Specializes in securities investment, trading, and portfoli…
|
501148 | IN | Financial and insurance activit… |
|
DALMIA INDUSTRIAL DEVELOPMENT LIMITED
Investment firm managing securities, providing credit, and …
|
539900 | IN | Financial and insurance activit… |
LIGAND PHARMACEUTICALS INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31289/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31289 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31289 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31289 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31289}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for LIGAND PHARMACEUTICALS INC (id: 31289)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.